3 results
Approved WMOCompleted
The primary objective is to evaluate the safety of ReFacto AF in previously untreated patients (no prior exposure to factor products or any blood products) of less than 6 years of age.
Approved WMORecruiting
1. Are telemedicine and FTF-evaluation similar?2. Are TM-evaluation from a general practitioners office and FTF-evaluation similar? 3. How do parents/patients value the TM evaluation?4. How do general practitioners and paediatricians value the TM…
Approved WMOCompleted
The primary objective of this study is to evaluate the efficacy of TDF plus Peginterferon *-2a (PEG) combination therapy for 48 weeks versus standard of care TDF monotherapy or PEG monotherapy for 48 weeks in non-cirrhotic CHB subjects as determined…